Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]:
SEC Accession No. 0001079973-25-000516
Filing Date
2025-03-28
Accepted
2025-03-28 17:29:40
Documents
67
Period of Report
2024-12-31

Document Format Files

Seq Description Document Type Size
1 ANNUAL REPORT pktx_10k-123124.htm   iXBRL 10-K 759661
2 DESCRIPTION OF OUR SECURITIES ex4x6.htm EX-4.6 20020
3 INSIDER TRADING POLICY, AMENDED ex19x1.htm EX-19.1 34814
4 POLICY ON TRADING BLACKOUT PERIODS ADOPTED JULY 8, 2019 ex19x2.htm EX-19.2 23689
5 EXHIBIT 31.1 ex31x1.htm EX-31.1 15327
6 EXHIBIT 31.2 ex31x2.htm EX-31.2 15669
7 EXHIBIT 31.1 ex32x1.htm EX-32.1 6600
8 GRAPHIC davidson.jpg GRAPHIC 13440
9 GRAPHIC image_003.jpg GRAPHIC 13613
  Complete submission text file 0001079973-25-000516.txt   3769149

Data Files

Seq Description Document Type Size
10 XBRL SCHEMA FILE pktx-20241231.xsd EX-101.SCH 28407
11 XBRL CALCULATION FILE pktx-20241231_cal.xml EX-101.CAL 28739
12 XBRL DEFINITION FILE pktx-20241231_def.xml EX-101.DEF 82057
13 XBRL LABEL FILE pktx-20241231_lab.xml EX-101.LAB 266252
14 XBRL PRESENTATION FILE pktx-20241231_pre.xml EX-101.PRE 216222
69 EXTRACTED XBRL INSTANCE DOCUMENT pktx_10k-123124_htm.xml XML 396823
Mailing Address 109 W. MAIN ST. DALTON OH 44618
Business Address 109 W. MAIN ST. DALTON OH 44618 330-445-4971
ProtoKinetix, Inc. (Filer) CIK: 0001128189 (see all company filings)

EIN.: 943355026 | State of Incorp.: NV | Fiscal Year End: 1231
Type: 10-K | Act: 34 | File No.: 000-32917 | Film No.: 25788006
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)